Publication | Closed Access

Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)

MedicineParkinson DiseaseDementiaVascular DementiaNeurologyAging-associated DiseaseNeurodegenerationPharmacologyTreatment